MAGENTA THERAPEUTICS, INC. [ • ] Shares of Common Stock Underwriting AgreementUnderwriting Agreement • April 29th, 2019 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • New York
Contract Type FiledApril 29th, 2019 Company Industry Jurisdiction
FIRST AMENDMENT TO SUBLEASE AGREEMENTSublease Agreement • April 29th, 2019 • Magenta Therapeutics, Inc. • Pharmaceutical preparations • Massachusetts
Contract Type FiledApril 29th, 2019 Company Industry JurisdictionThis FIRST AMENDMENT TO SUBLEASE AGREEMENT (this “First Amendment”) is dated as of December 13, 2018 (the “Effective Date”) by and between NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC., a Delaware corporation, having an address at 100 Technology Square, Cambridge Massachusetts 02139 (“Novartis”), and MAGENTA THERAPEUTICS, INC., a Delaware corporation, having an address at 50 Hampshire Street, 8th Floor, Cambridge Massachusetts 02139 (“Subtenant”).